Issue 29 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

37

No.

29

July 22, 2011Jul 22, 2011

Free

DOWNLOAD THE PDF

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

Part One Of A Two-Part Interview With NCI Director Harold Varmus

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

Richard Pazdur’s Comments to ODAC

Department of Defense Offering $16 Million in Cancer Research Grants

Recent Issues

Volume 52 | Issue 32 - August 14, 2026

Volume 52 | Issue 31 - August 07, 2026

Volume 52 | Issue 30 - July 31, 2026

Volume 52 | Issue 29 - July 24, 2026

Volume 52 | Issue 28 - July 17, 2026

Volume 52 | Issue 27 - July 10, 2026